|
 |
|
 |
 |
Name:
Sector:
Chief Executive:
|
NitroMed
Healthcare
Kenneth Bate
|
|
|
Summary:
|
A platform technology company that relies on the principles
of medicinal chemistry to form NitRx™ medicines. The technology
seeks to extend the life cycle of products by synthesizing new,
proprietary compounds that improve the parent medicine's safety
or efficacy.
|
|
|
Stage of Initial
Investment:
|
Venture |
Liquidity:
|
IPO
(NASDAQ: NTMD)
|
|
|
|
|
|
|
|
 |
| |
45 Hayden Road
Suite 3000
Lexington,
MA 02421
Phone: 781.266.4000
Fax: 781.274.8080 |
|
 |
|
|
|
